Literature DB >> 7507299

CD40 expression in Hodgkin's disease.

J T O'Grady1, S Stewart, J Lowrey, S E Howie, A S Krajewski.   

Abstract

CD40 is a transmembrane protein that belongs to a superfamily of proteins related to nerve growth factor receptor. CD40 is expressed on B cells and some B cell malignancies. It appears to be involved in B cell proliferation and the prevention of apoptosis in germinal center cells, which is accompanied by expression of bcl-2. Its expression is up-regulated by the EBV protein latent membrane protein-1 and cytokines interleukin-4 and interferon-gamma. The expression of CD40 in 37 cases of Hodgkin's disease and 23 cases of non-Hodgkin's lymphoma (11 T cell lymphomas and 12 B cell lymphomas) was examined by paraffin section immunohistochemistry using the BB-20 monoclonal antibody. In 26 of 37 cases of Hodgkin's disease the Reed-Sternberg cells showed strong membrane or cytoplasmic expression of CD40. Only 3 of 23 non-Hodgkin's lymphomas showed any expression of CD40 and then only weakly. There was no correlation between expression of bcl-2 or latent membrane protein-1 with CD40 expression. These results show that there is probable hyperexpression of CD40 in Hodgkin's disease and suggest that dysregulation of CD40 expression may play a role in the pathogenesis of Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507299      PMCID: PMC1887112     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  Mechanism of antigen-driven selection in germinal centres.

Authors:  Y J Liu; D E Joshua; G T Williams; C A Smith; J Gordon; I C MacLennan
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

2.  Expression of T-cell-receptor beta chain in Reed-Sternberg cells.

Authors:  F E Dallenbach; H Stein
Journal:  Lancet       Date:  1989-10-07       Impact factor: 79.321

3.  Nodular sclerosing, mixed cellularity and lymphocyte-depleted variants of Hodgkin's disease are probable dendritic cell malignancies.

Authors:  I C Kennedy; D N Hart; B M Colls; J C Nimmo; D A Willis; H B Angus
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

4.  Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40.

Authors:  S Braesch-Andersen; S Paulie; H Koho; H Nika; P Aspenström; P Perlmann
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

5.  Resting B lymphocytes can be triggered directly through the CDw40 (Bp50) antigen. A comparison with IL-4-mediated signaling.

Authors:  J Gordon; M J Millsum; G R Guy; J A Ledbetter
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

6.  Activation of human B lymphocytes through CD40 and interleukin 4.

Authors:  A Vallé; C E Zuber; T Defrance; O Djossou; M De Rie; J Banchereau
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

7.  Human B lymphoma cell line producing B cell growth factor.

Authors:  J L Ambrus; A S Fauci
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.

Authors:  H Herbst; G Tippelmann; I Anagnostopoulos; J Gerdes; R Schwarting; T Boehm; S Pileri; D B Jones; H Stein
Journal:  Leuk Res       Date:  1989       Impact factor: 3.156

9.  Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).

Authors:  J A Ledbetter; G Shu; M Gallagher; E A Clark
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

10.  A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas.

Authors:  I Stamenkovic; E A Clark; B Seed
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  4 in total

1.  CD40 antigen expression on Reed-Sternberg cells. A reliable diagnostic tool for Hodgkin's disease.

Authors:  A Carbone; A Gloghini; H J Gruss; A Pinto
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

2.  Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?

Authors:  G S Pinkus; J L Pinkus; E Langhoff; F Matsumura; S Yamashiro; G Mosialos; J W Said
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 3.  The Microenvironment in Epstein-Barr Virus-Associated Malignancies.

Authors:  Geok Wee Tan; Lydia Visser; Lu Ping Tan; Anke van den Berg; Arjan Diepstra
Journal:  Pathogens       Date:  2018-04-13

4.  Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40.

Authors:  E Oflazoglu; I J Stone; L Brown; K A Gordon; N van Rooijen; M Jonas; C-L Law; I S Grewal; H-P Gerber
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.